Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.
about
RNA dimerization defect in a Rous sarcoma virus matrix mutant.Complex interactions of HIV-1 nucleocapsid protein with oligonucleotidesStructural determinants and mechanism of HIV-1 genome packagingRole of the DIS hairpin in replication of human immunodeficiency virus type 1Human cellular nucleic acid-binding protein Zn2+ fingers support replication of human immunodeficiency virus type 1 when they are substituted in the nucleocapsid proteinIs HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?Wrapping up the bad news: HIV assembly and releaseThe choreography of HIV-1 proteolytic processing and virion assemblyCation-dependent cleavage of the duplex form of the subtype-B HIV-1 RNA dimerization initiation siteThe Life-Cycle of the HIV-1 Gag-RNA ComplexMultiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication.Viral DNA synthesis defects in assembly-competent Rous sarcoma virus CA mutants.Long-range recombination gradient between HIV-1 subtypes B and C variants caused by sequence differences in the dimerization initiation signal region.Infectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro.Secondary structure of the mature ex virio Moloney murine leukemia virus genomic RNA dimerization domainDelineation of the preferences and requirements of the human immunodeficiency virus type 1 dimerization initiation signal by using an in vivo cell-based selection approach.C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism.The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.Studies of the genomic RNA of leukosis viruses: implications for RNA dimerization.Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.Analysis of the contribution of reverse transcriptase and integrase proteins to retroviral RNA dimer conformation.Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides.The genomic RNA in Ty1 virus-like particles is dimericRescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.Characterization of the block in replication of nucleocapsid protein zinc finger mutants from moloney murine leukemia virus.trans-acting inhibition of genomic RNA dimerization by Rous sarcoma virus matrix mutantsMaintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.Preliminary physical mapping of RNA-RNA linkages in the genomic RNA of Moloney murine leukemia virus.Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.An immature retroviral RNA genome resembles a kinetically trapped intermediate stateMolecular mechanisms of simian immunodeficiency virus SIV(agm) RNA encapsidationBinding characteristics of small molecules that mimic nucleocapsid protein-induced maturation of stem-loop 1 of HIV-1 RNA.Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNARIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I.Effects of Gag mutation and processing on retroviral dimeric RNA maturation.Ty3 integrase is required for initiation of reverse transcriptionSingle-molecule FRET studies of important intermediates in the nucleocapsid-protein-chaperoned minus-strand transfer step in HIV-1 reverse transcription.Proline residues within spacer peptide p1 are important for human immunodeficiency virus type 1 infectivity, protein processing, and genomic RNA dimer stability.A structural linkage between the dimerization and encapsidation signals in HIV-2 leader RNA.
P2860
Q24524289-438EACC3-641E-4B49-B17A-831EAD4199A6Q24539163-186D6BBD-BE58-44A6-A3E1-51F566EA2A76Q24632055-82937A5F-71EE-434F-AC90-5825864B498CQ24680551-D4C8E803-A15B-477F-8214-31F9E9A013D7Q24682466-968C8C8C-D6D5-4DC1-B505-5B439E2D312BQ24805927-A3872EDD-68DF-4A6E-8AA1-14288FA5CF95Q26992150-2303B0A1-99C4-4454-AA77-37BB3DFD02C2Q27009643-3042127F-4CC0-4350-B74A-E635B10B46D1Q27661496-9B10FC73-523D-4104-801D-ADB08E007937Q28076985-62B097AD-A5E7-4D3C-96DA-CEDAE0C427A0Q28343701-81585FD6-56EC-4422-9DD7-14C5255A1172Q30327614-DCF5A33D-977B-42B7-9078-5126003B65FEQ30368029-13369AF0-1510-43EF-B39C-D8867DF5F5FFQ30430249-5AC9FC70-ACCC-4BF9-98A5-0927C3F2549AQ33558378-8EC31E4C-6E6B-4E23-A0C9-DD7FCF4BFEDFQ33561552-5FA9EBBF-F903-47F7-BAF3-EF99715FEDE7Q33581258-ECE28648-7CAB-4CBD-B463-D21C433FBBA3Q33647840-E5EDF4A0-D29E-4159-9209-44F7E65157BCQ33648835-E44DFD14-ABC0-4499-AE3C-6B519AA206E8Q33707470-99B25D94-5BF4-4EB8-A9B4-7454B5026600Q33780519-5F79157B-6BEE-4CCE-9D80-2E1BFA0E4224Q33782302-147D1560-388D-4927-9B46-378D80E1F255Q33787384-8C949702-AF56-412B-89BB-6DB808795690Q33803814-1873EE8B-9A07-43CC-971A-9413E1CA87CBQ33819451-06CC31FB-0FB6-4210-A6F4-7D81DAD1F0CFQ33834799-88925BC7-12C4-4D2D-AA10-C1D5E4DB8CC4Q33837707-A750917D-50F5-4C96-A603-F6EA60DC61B5Q33843452-FCC6A97D-DA50-4C4B-AD88-D9B65D402EFEQ33845445-8AD37F65-E95E-4DCC-8FF7-75D381412F90Q33845811-DDC12483-EFE3-4F19-BA8D-B13FB1757227Q33887851-787D6CDB-5310-4057-8C1B-71C23AEFD4CDQ34062113-B6C5AA30-E6E9-453C-9A05-B9A6B1EED019Q34066427-329EFAA1-E5EE-459D-B693-B3FF7FE93640Q34138829-EC0A87B4-FFCE-4CA1-A359-18AD9AF6D784Q34150344-C608F29A-648A-4308-A625-799DC5006A1EQ34302140-CC5BE414-DD44-439D-A812-198B883B3EB9Q34332190-ACF813BC-728E-4C56-8814-E4EEA6C2FC87Q34351841-1B493DD5-5566-41B1-80DF-1309F7FDA345Q34354549-BC663760-935C-4506-B9DD-98F77EE4EA76Q34365248-77C7FBA0-2E29-4B38-98F9-4764E5A4DD7D
P2860
Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Characterization of human immu ...... nd protease-defective virions.
@ast
Characterization of human immu ...... nd protease-defective virions.
@en
type
label
Characterization of human immu ...... nd protease-defective virions.
@ast
Characterization of human immu ...... nd protease-defective virions.
@en
prefLabel
Characterization of human immu ...... nd protease-defective virions.
@ast
Characterization of human immu ...... nd protease-defective virions.
@en
P2093
P2860
P1433
P1476
Characterization of human immu ...... nd protease-defective virions.
@en
P2093
P2860
P304
P407
P577
1994-08-01T00:00:00Z